Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous AMD3100 + G-CSF for Stem Cell Mobilization in Lymphoma
NCT00733824Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2008
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in lymphoma, sponsored by Washington University School of Medicine. Started Nov 2008; status: completed.
02
Drugs
plerixafor
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT00733824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733824.